Pacira Therapeutics Revenue, Growth & Competitor Profile

DBA (A DELEOPMENT STAGE ENTERPRISE)
DBA FLEXION THERAPEUTICS

Company Profile & Annual Report for Pacira Therapeutics

Access the complete profile.

Pacira Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	5 Sylvan Way Parsippany, NJ 07054

Pacira Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Pacira Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Pacira Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Pacira Therapeutics is a publicly traded company on NGM using the ticker symbol FLXN. Detailed information on company financials and operating reports can be found here: NGM: FLXN

Pacira Therapeutics Annual Revenue and Growth Rate

Pacira Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Pacira Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Pacira Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 14, 2012	7	100%	$20 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Pacira Therapeutics is developing and marketing. Pacira Therapeutics doesn't have any recent trademark applications, indicating Pacira Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
FLEXFORWARD Providing information regarding insurance coverage by means of an online portal and call center; providing information regarding prescription drug insurance coverage for physicians and patients; administration of a patient assistance program for providing prescription drugs at reduced prices to patients, and providing information related thereto via a call center	05/19/2017
FXTEND Drug delivery agents in the form of dissolvable microspheres that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds, being a component in pharmaceutical preparations, that facilitate delivery of a wide range of pharmaceuticals	10/05/2016
Z Research and development of pharmaceutical preparations, products and technology in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, and new therapies for pain, inflammation and functional impairment of joints; medical and scientific research and development in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, and new therapies for pain, inflammation and functional impairment of joints; providing medical and scientific research information in the fields of musculoskeletal conditions, soft tissue conditions, and arthritis, new therapies for pain, inflammation and functional impairment of joints; pharmaceuticals and clinical trials; scientific investigations for medical purposes; medical research	10/05/2016

See all trademarks and details in the Full Report.

Market Share of Pacira Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Pacira Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Pacira Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SOLVIAS	Fort Lee, NJ	100
HISENSE PHOTONICS	South Plainfield, NJ	46
PACIRA THERAPEUTICS	Parsippany, NJ	35
PANDION THERAPEUTICS	Rahway, NJ	25
ELEVAR THERAPEUTICS	Fort Lee, NJ	21
MAXENTRIC TECHNOLOGIES	Fort Lee Borough, NJ	16

Future Competition: Pacira Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Pacira Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)